{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:19:59Z","timestamp":1787872799142,"version":"build-2784847793"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":99,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-026-06113-9","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T18:57:16Z","timestamp":1779389836000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recurrent optic neuritis as the first presentation of monoclonal gammopathy of undetermined significance: a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Ahmad","family":"Pourmohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Naghavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Adibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"6113_CR1","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1182\/blood.2019846782","volume":"133","author":"TH Mouhieddine","year":"2019","unstructured":"Mouhieddine TH, Weeks LD, Ghobrial IM. Monoclonal gammopathy of undetermined significance. Blood. 2019;133:2484\u201394. https:\/\/doi.org\/10.1182\/blood.2019846782.","journal-title":"Blood"},{"key":"6113_CR2","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00277-021-04400-7","volume":"100","author":"MA Castaneda-Avila","year":"2021","unstructured":"Castaneda-Avila MA, Ulbricht CM, Epstein MM. Risk factors for monoclonal gammopathy of undetermined significance: a systematic review. Ann Hematol. 2021;100:855\u201363. https:\/\/doi.org\/10.1007\/s00277-021-04400-7.","journal-title":"Ann Hematol"},{"key":"6113_CR3","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3390\/cancers12061554","volume":"12","author":"OC Lomas","year":"2020","unstructured":"Lomas OC, Mouhieddine TH, Tahri S, Ghobrial IM. Monoclonal gammopathy of undetermined significance (MGUS)\u2014not so asymptomatic after all. Cancers. 2020;12:1554. https:\/\/doi.org\/10.3390\/cancers12061554.","journal-title":"Cancers"},{"key":"6113_CR4","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos M-V, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538\u201348. https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5.","journal-title":"Lancet Oncol"},{"key":"6113_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/ana.410220520","volume":"22","author":"S Barbieri","year":"1987","unstructured":"Barbieri S, Nobile\u2010Orazio E, Baldini L, Fayoumi Z, Manfredini E, Scarlato G. Visual evoked potentials in patients with neuropathy and macroglobulinemia. Ann Neurol. 1987;22:663\u20136. https:\/\/doi.org\/10.1002\/ana.410220520.","journal-title":"Ann Neurol"},{"key":"6113_CR6","doi-asserted-by":"publisher","first-page":"e237726","DOI":"10.1136\/bcr-2020-237726","volume":"14","author":"L Prakhova","year":"2021","unstructured":"Prakhova L, Lebedev V, Ilves A, Nazinkina Y. Monoclonal gammopathy of undetermined significance (MGUS) manifestation in CNS: a regular or chance occurrence? BMJ Case Rep. 2021;14:e237726. https:\/\/doi.org\/10.1136\/bcr-2020-237726.","journal-title":"BMJ Case Rep"},{"key":"6113_CR7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/1756-185X.12267","volume":"17","author":"SY Cho","year":"2014","unstructured":"Cho SY, Yang H, Jeon YL, You E, Lee HJ, Yoon H, et al. A case series of autoimmune diseases accompanied by incidentally diagnosed monoclonal gammopathy: is there a link between the two diseases? Int J Rheum Dis. 2014;17:635\u20139. https:\/\/doi.org\/10.1111\/1756-185X.12267.","journal-title":"Int J Rheum Dis"},{"key":"6113_CR8","first-page":"483","volume":"24","author":"E Gali\u00e8","year":"2005","unstructured":"Gali\u00e8 E, Maschio M, Jandolo B. Cerebellar atrophy and monoclonal gammopathy of undetermined significance: a possible correlation? J Exp Clin Cancer Res. 2005;24:483\u20135.","journal-title":"J Exp Clin Cancer Res"},{"key":"6113_CR9","doi-asserted-by":"publisher","first-page":"282","DOI":"10.4236\/wjns.2013.34038","volume":"03","author":"E Gali\u00e8","year":"2013","unstructured":"Gali\u00e8 E, Acqua MLD, Maschio M, Koudriavtseva T, Marco ED, Jandolo B. Central and peripheral neurological involvement in monoclonal gammopathies of undetermined significance. World J Neurosurg. 2013;03:282\u20136. https:\/\/doi.org\/10.4236\/wjns.2013.34038.","journal-title":"World J Neurosurg"},{"key":"6113_CR10","first-page":"337","volume":"22","author":"E Gali\u00e8","year":"2003","unstructured":"Gali\u00e8 E, Pietrangeli A, Maschio M, Pace A, Vidiri A, Carosi M, et al. Demyelinating disease in monoclonal gammopathy of undetermined significance. J Exp Clin Cancer Res. 2003;22:337\u20139.","journal-title":"J Exp Clin Cancer Res"},{"key":"6113_CR11","first-page":"253","volume":"19","author":"M Rentzos","year":"2004","unstructured":"Rentzos M, Michalopoulou M, Gotosidis K, Caponi A, Bonakis A, Kilidireas K, et al. Unusual association of multiple sclerosis with monoclonal gammopathy of undetermined significance (MGUS): two case reports. Funct Neurol. 2004;19:253\u20136.","journal-title":"Funct Neurol"},{"key":"6113_CR12","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1001\/archneur.64.10.1531","volume":"64","author":"L Benedetti","year":"2007","unstructured":"Benedetti L, Franciotta D, Vigo T, Grandis M, Fiorina E, Ghiglione E, et al. Relapses after treatment with rituximab in a patient with multiple sclerosis and anti-myelin-associated glycoprotein polyneuropathy. Arch Neurol. 2007;64:1531. https:\/\/doi.org\/10.1001\/archneur.64.10.1531.","journal-title":"Arch Neurol"},{"key":"6113_CR13","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1212\/NXI.0000000000000061","volume":"2","author":"JS Perumal","year":"2015","unstructured":"Perumal JS, Kister I, Howard J, Herbert J. Disease exacerbation after rituximab induction in neuromyelitis optica. Neurol Neuroimmunol Neuroinflamm. 2015;2:e61. https:\/\/doi.org\/10.1212\/NXI.0000000000000061.","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-026-06113-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-06113-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-06113-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:02:53Z","timestamp":1787871773000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13256-026-06113-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6113"],"URL":"https:\/\/doi.org\/10.1186\/s13256-026-06113-9","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"7 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study as approved by the Iranian national committee for ethics in biomedical research (Approval ID: IR.ARI.MUI.REC.1400.065) and performed in accordance with the Helsinki Declaration of 1964, and its later amendment.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ahmad Pourmohammadi, Saba Naghavi, and Iman Adibi declare that they have no competing of interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"507"}}